BioLife Solutions, Inc.

NasdaqCM:BLFS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

📦 Containers & Packaging

🚚 Logistics & Freight

🩺 Medical Instruments

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 1.24 B

Share Price

USD 25.91

Avg Daily Volume

565,440

Change (1 day)

3.31%

Change (1 year)

5.97%

Change (YTD)

-0.19%

BioLife Solutions, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -13.72%

BioLife Solutions, Inc. Operating Income Margin is -13.72% for the Trailing 12 Months (TTM) ending September 30, 2024, a -57.77% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

BioLife Solutions, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -32.49%, a 7.19% change year over year.
BioLife Solutions, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -30.31%, a 36.58% change year over year.
BioLife Solutions, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -22.19%, a 366.60% change year over year.
BioLife Solutions, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -4.76%, a -162.86% change year over year.